EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Inhibition of ATM-directed antiviral responses by HIV-1 Vif

Hoi Tong Wong, Adeline M Luperchio, Sean Riley, Daniel J Salamango iD

PLOS Pathogens · 05.09.2023 · 19 (9) · e1011634

DOI: 10.1371/journal.ppat.1011634 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS Pathogens, online erschienen am 05.09.2023. Verfasst von Hoi Tong Wong und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Stony Brook University, Stony Brook, New York, United States of America. Hauptthemen laut MEDLINE: HIV-1, HIV Seropositivity. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 87 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, Division of Intramural Research, National Institute of Allergy and Infectious Diseases.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Emerging evidence indicates that HIV-1 hijacks host DNA damage repair (DDR) pathways to facilitate multiple facets of virus replication. Canonically, HIV-1 engages proviral DDR responses through the accessory protein Vpr, which induces constitutive activation of DDR kinases ATM and ATR. However, in response to prolonged DDR signaling, ATM directly induces pro-inflammatory NF-κB signaling and activates multiple members of the TRIM family of antiviral restriction factors, several of which have been previously implicated in antagonizing retroviral and lentiviral replication. Here, we demonstrate that the HIV-1 accessory protein Vif blocks ATM-directed DNA repair processes, activation of NF-κB signaling responses, and TRIM protein phosphorylation. Vif function in ATM antagonism occurs in clinical isolates and in common HIV-1 Group M subtypes/clades circulating globally. Pharmacologic and functional studies combine to suggest that Vif blocks Vpr-directed activation of ATM but not ATR, signifying that HIV-1 utilizes discrete strategies to fine-tune DDR responses that promote virus replication while simultaneously inhibiting immune activation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV-1HIV SeropositivityHumansNF-kappa BPhosphorylationAntiviral Restriction FactorsAntiviral AgentsAtaxia Telangiectasia Mutated Proteins

Substanzen

NF-kappa BAntiviral Restriction FactorsAntiviral AgentsATM protein, humanAtaxia Telangiectasia Mutated Proteins

Autor:innen und Institutionen

  • Department of Microbiology and Immunology, Stony Brook University, Stony Brook, New York, United States of America.

ORCID-Profile: Daniel J Salamango

Förderung

  • NIAID NIH HHS
  • NIGMS NIH HHS
  • Division of Intramural Research, National Institute of Allergy and Infectious Diseases
  • National Institute of General Medical Sciences

Zitieren

APA

Wong, H. T., Luperchio, A. M., Riley, S., & Salamango, D. J. (2023). Inhibition of ATM-directed antiviral responses by HIV-1 Vif. PLOS Pathogens, 19(9), e1011634. https://doi.org/10.1371/journal.ppat.1011634

Vancouver

Wong HT, Luperchio AM, Riley S, Salamango DJ. Inhibition of ATM-directed antiviral responses by HIV-1 Vif. PLOS Pathogens. 2023;19(9):e1011634. doi:10.1371/journal.ppat.1011634

BibTeX
@article{Wong2023,
  author = {Wong, Hoi Tong and Luperchio, Adeline M and Riley, Sean and Salamango, Daniel J},
  title = {Inhibition of ATM-directed antiviral responses by HIV-1 Vif},
  journal = {PLOS Pathogens},
  year = {2023},
  volume = {19},
  number = {9},
  pages = {e1011634},
  doi = {10.1371/journal.ppat.1011634}
}
Kostenlos starten →